203 results
8-K
EX-10.1
RGBP
Regen BioPharma, Inc.
13 Sep 24
Entry into a Material Definitive Agreement
2:12pm
. The Company and each of its subsidiaries maintains a system of internal accounting controls sufficient to provide reasonable assurance that (i
424B3
RGBP
Regen BioPharma, Inc.
24 Apr 24
Prospectus supplement
1:28pm
for the marketing and sale of any of the Company’s products and therapies and no assurance may be given that any of the Company’s products or therapies … or, alternatively, advance the application further to Phase III clinical trials. The Company can provide no assurance that the Company will be able
424B3
0ug54e
19 Jan 24
Prospectus supplement
1:29pm
424B3
EX-31.2
3gw twe3g
20 Nov 23
Prospectus supplement
9:38am
424B3
8i3rldql44bdv3glx
20 Nov 23
Prospectus supplement
9:38am
424B3
EX-31.1
5mjf2j
20 Nov 23
Prospectus supplement
9:38am
424B3
1kbhs7
2 Oct 23
Prospectus supplement
1:42pm